BioImpact Equities Fund, LP — Form D/A
BioImpact Equities Fund, LP of BOSTON, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2021-12-21. $72.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-12-21
- Form: D/A
- Accession: 0001567619-21-022381
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.7
- Amount sold: $72.4M
- Investors: 43
- Date of first sale: 2011-01-01
- Security types: fund interests
- SEC file number: 021-363866
Issuer
- Name: BioImpact Equities Fund, LP
- CIK: 0001807882
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Address: 399 BOYLSTON STREET, SUITE 1100, BOSTON, MA, 02116
- Phone: 617-410-4770
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Christopher Goh Wolf | Executive Officer | Boston, MA |
| Christiana Goh Bardon | Executive Officer | Boston, MA |
| Christiana Goh Bardon | Related Person | Boston, MA |
| Kristen Goh Laguerre | Executive Officer | Boston, MA |
| n/a BioImpact Equities LLC | Executive Officer | Boston, MA |
| n/a BioImpact Equities LLC | Related Person | Boston, MA |
| n/a Burrage Capital, LLC | Executive Officer | Boston, MA |
| Howard B Rubin | Executive Officer | Boston, MA |
| Kristen Laguerre | Related Person | Boston, MA |
| Christopher Wolf | Related Person | Boston, MA |
Other filings by this issuer (6)
More